Publications by authors named "Ron P Schuring"

Claim this Profile
O
One-year follow-up of the immunogenicity and safety of a first and second booster dose of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Final report of a phase 3 open-label trial.
Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P Schuring

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial.
Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P Schuring

Vaccine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial.
Kenji Kuriyama, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P Schuring

Vaccine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial.
Kenji Kuriyama, Kyoko Murakami, Taisei Masuda, Kenkichi Sugiura, Sho Sakui, Ron P Schuring

Vaccine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.
Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P Schuring

Vaccine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing nerve function impairment in leprosy: validation and updating of a prediction rule.
Ron P Schuring, Jan H Richardus, Ewout W Steyerberg, David Pahan, William R Faber

PLoS Negl Trop Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.
Ron P Schuring, Jan Hendrik Richardus, David Pahan, Linda Oskam

Vaccine· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy.
Lutz Hamann, Oliver Kumpf, Ron P Schuring, Erkan Alpsoy, George Bedu-Addo

BMC Med Genet· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions.
Ron P Schuring, Lutz Hamann, William R Faber, David Pahan, Jan Hendrik Richardus

J Infect Dis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh.
Fake J Moet, Ron P Schuring, David Pahan, Linda Oskam, Jan Hendrik Richardus

PLoS Negl Trop Dis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between anti-pGL-I IgM and clinical and demographic parameters in leprosy.
Ron P Schuring, F Johannes Moet, David Pahan, Jan Hendrik Richardus, Linda Oskam

Lepr Rev· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy.
F Johannes Moet, David Pahan, Ron P Schuring, Linda Oskam, Jan H Richardus

J Infect Dis· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis